Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions.
Alvarez-Twose I, Matito A, Sánchez-Muñoz L, Morgado JM, Orfao A, Escribano L, van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG. Alvarez-Twose I, et al. Allergy. 2012 Sep;67(9):1190-1. doi: 10.1111/j.1398-9995.2012.02850.x. Allergy. 2012. PMID: 22882359 No abstract available.
Prevalence of indolent systemic mastocytosis in a Dutch region.
van Doormaal JJ, Arends S, Brunekreeft KL, van der Wal VB, Sietsma J, van Voorst Vader PC, Oude Elberink JN, Kluin-Nelemans JC, van der Veer E, de Monchy JG. van Doormaal JJ, et al. J Allergy Clin Immunol. 2013 May;131(5):1429-31.e1. doi: 10.1016/j.jaci.2012.10.015. Epub 2012 Dec 6. J Allergy Clin Immunol. 2013. PMID: 23219169 No abstract available.
CD30 in systemic mastocytosis.
van Anrooij B, Kluin PM, Oude Elberink JN, Kluin-Nelemans JC. van Anrooij B, et al. Immunol Allergy Clin North Am. 2014 May;34(2):341-55. doi: 10.1016/j.iac.2014.01.006. Epub 2014 Mar 13. Immunol Allergy Clin North Am. 2014. PMID: 24745678 Review.
Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial.
van Anrooij B, Oude Elberink JNG, Span LFR, de Monchy JGR, Rosati S, Mulder AB, Kluin-Nelemans JC. van Anrooij B, et al. Among authors: kluin nelemans jc. J Allergy Clin Immunol. 2018 Sep;142(3):1006-1008.e7. doi: 10.1016/j.jaci.2018.06.003. Epub 2018 Jun 8. J Allergy Clin Immunol. 2018. PMID: 29890238 Clinical Trial. No abstract available.
153 results